35863-45-7

Upstream product

• 101518-61-0 2,2-dimethyl-3-phenylpropanamide 
• 925-90-6 ethylmagnesium bromide 
• 108-88-3 toluene 
• 645-59-0 dihydrocinnamonitrile 
• 74-88-4 methyl iodide 
• 78-82-0 Isobutyronitrile 
• 100-39-0 benzyl bromide 
• 1195-42-2 N-cyclohexylisopropylamine 
• 100-44-7 benzyl chloride 
• 100-51-6 benzyl alcohol 
• 1453071-02-7 2-methyl-2-(phenylsulfinyl)propanenitrile 
• 538-93-2 1-phenyl-2-methylpropane 
• 19158-51-1 P-toluenesulfonyl cyanide 
• 851233-80-2 potassium 2-cyano-2-methyl-propanoate 

Downstream Products

• 5669-14-7 2,2-dimethyl-3-phenylpropanoic acid 
• 27336-91-0 Diazo-1-dimethyl-3,3-phenyl-4-butanon-2 
• 62931-24-2 2,2-dimethyl-3-phenylpropanoyl chloride 
• 1620165-24-3 C₁₄H₁₉NO 
• 1620165-47-0 (Z)-N-(2,2-dimethyl-1-phenyl-6-(triisopropylsilyl)hex-3-en-5-yn-3-yl)acetamide 
• 1416437-73-4 5,5-dimethyl-1,2,4-triphenyl-1,4,5,6-tetrahydropyrimidine 
• 95141-79-0 2,2-dimethyl-3-phenylpropan-1-amine 
• 1416437-85-8 N-(2,2-dimethyl-3-phenylpropyl)aniline 
• 1416437-68-7 N-(2,2-dimethyl-3-phenylpropyl)-N-phenylbenzimidamide 
• 760999-19-7 2,5-bis(1,1-dimethyl-2-phenylethyl)-2,4-dihydroxyfuran-3(2H)-one 
• 760999-16-4 2,2,7,7-tetramethyl-1,8-diphenyloctane-3,4,5,6-tetraone 
• 760999-17-5 3,3-dimethyl-2-oxo-4-phenylbutyraldehyde 
• 1009-62-7 2,2-dimethyl-3-phenylpropionaldehyde 
• 880085-65-4 9-(N,N-dibenzylamino)-2,2-dimethyl-1-phenylnon-4-yn-3-yl methyl carbonate 

Relevant academic research and scientific papers

Direct C(sp3)-H Cyanation Enabled by a Highly Active Decatungstate Photocatalyst

A highly efficient, direct C(sp3)-H cyanation was developed under mild photocatalytic conditions. The method enabled the direct cyanation of various C(sp3)-H substrates with excellent functional group tolerance. Notably, complex natural products and bioactive compounds were efficiently cyanated.

Discovery of highly potent renin inhibitors potentially interacting with the S3' subsite of renin

To exploit the S3′ subsite of renin active site for renin inhibitor design, 42 aliskiren derivatives with modified P2' portion were designed, synthesized and biologically evaluated. Some highly potent renin inhibitors (IC50 50 Combining double low line 0.9 nM) and 39 (IC50 Combining double low line 0.7 nM) were over 2.5-fold more potent than aliskiren (IC50 Combining double low line 2.3 nM). SAR analysis indicated that incorporation of polar hydrophilic moieties into the P2' portion of renin inhibitors generally enhanced the potency. Consistently with this, molecular modeling study revealed that the triazole part of 39 could provide additional interactions to the S3' subsite of renin active site. Moreover, in vivo evaluation in the double transgenic mouse hypertension model demonstrated that 39 produced greater reduction of the mean arterial blood pressure than ariskiren at the doses of 17.0 and 34.0 1/4mol/kg, respectively. Taken together, the S3' subsite of renin active site merits further consideration for renin inhibitor design.

Rhodium(iii)-catalyzed olefinic C-H alkynylation of enamides at room temperature

Rh(iii)-catalyzed C-H olefinic alkynylation of enamides for the stereospecific construction of synthetically useful Z-type enynamides is reported. This protocol displays good functionality tolerance and operational simplicity thus providing an alternative synthetic opportunity for the ease of access to specific 1,3-enyne derivatives.

Sulfinylnitriles: Sulfinyl-metal exchange-alkylation strategies

Adding organolithiums, Grignard reagents, or zincates to sulfinylnitriles triggers a facile sulfinyl-metal exchange to afford N- or C-metalated nitriles. Sulfinyl-magnesium exchange-alkylations efficiently install quaternary and tertiary centers, even in

β-aryl nitrile construction via palladium-catalyzed decarboxylative benzylation of α-cyano aliphatic carboxylate salts

The palladium-catalyzed decarboxylative benzylation of α-cyano aliphatic carboxylate salts with benzyl electrophiles was discovered. This reaction exhibits good functional group compatibility and proceeds under relatively mild conditions. A diverse range of quaternary, tertiary and secondary β-aryl nitriles can be conveniently prepared by this method. Copyright

Novel selective anti-androgens with a diphenylpentane skeleton

We have proposed a multi-template approach for drug development, focusing on similar fold structures of proteins, and have effectively generated lead compounds for several drug targets. Modification of these polypharmacological lead compounds is then needed to generate target-selective compounds. In the work presented here, we aimed at separation of the anti-androgen activity and vitamin D activity of previously identified diphenylpentane lead compounds. Based on the determined X-ray crystal structures of androgen receptor and vitamin D receptor, bulky substituents were introduced at the t-butyl group in the lead compounds 2 and 3. As a result of this structural development, we obtained 16c, which exhibits more potent anti-androgen activity (IC 50: 0.13 μM) than clinically used anti-androgen bicalutamide (IC50: 0.67 μM) with 30-fold selectivity over vitamin D activity. This result indicates that lead compounds obtained via the multi-template approach can indeed be structurally modified to generate target-selective compounds.

Palladium(0)-catalyzed synthesis of chiral ene-allenes using alkenyl trifluoroborates

Enantioenriched allenes serve as chiral transfer reagents, making them attractive synthetic targets. Herein, the synthesis of enantioenriched allenes utilizing a Pd(0)-catalyzed cross-coupling reaction of propargylic carbonates and phosphates with alkenyl trifluoroborates is reported. Di-, tri-, and tetrasubstituted allenes were synthesized in moderate to high optical yields. Several racemic allenes possessing various functional groups were also synthesized.

Pyrazolopyrimidines as therapeutic agents

The present invention is directed to pyrazolopyrimidine derivatives of formula (I) wherein the substituents are defined herein, which are useful as kinase inhibitors and as such are useful for affecting angiogenesis and diseases and conditions associated with angiogenesis.

A cyclic vicinal bis(tetraketone) and structural investigations of formoins

Investigations of simple formoins such as 2,5-bis(1,1-dimethyl-2- phenylethyl)-2,4-dihydroxyfuran-3(2H)-one (17), benzoylformoin (18), p-toluoylformoin (19), pivaloylformoin (20), and the 2,4-dihydroxy-2,5- bis(heterocycl-2-yl)furan-3-ones 21-23 (heterocycle = furan, thiophene, selenophene) by NMR spectroscopy in DMSO showed the dihydroxyfuranone skeleton and not an enediol structure. The formoin 17 was oxidized to the corresponding tetraketone 10, The intermolecular double benzoin condensation of 1,4-bis(2,2-dimethyl-3,4-dioxobutyl)benzene (27) affords, in low yield, the bis(formoin) 29, and this could be oxidized to provide 2,2,2′,2′,7, 7,7′,7′-octamethyl[8.8]paracyclophan-3,3′,4,4′5, 5′6,6′-octaone (9). The molecular structures of 17 and 29, the monohydrate of 10 (30), and also the dihydrate of 9 (31) are reported. Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004.

Pyrazolopyrimidines as therapeutic agents

The present invention provides compounds of Formula I, including pharmaceutically acceptable salts and/or prodrugs thereof, where G, R2, and R3 are defined as described herein.